Target aims for Westlake Village
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
K-Swiss agrees to $170M buyout by Korean firm
Shares of Westlake Village-based footwear firm K-Swiss soared 48 percent on the morning of Jan. 17 after the company agreed to a $170 million buyout. E.Land World Ltd. of South Korea offered to pay $4.75 per share for K-Swiss, which has struggled with huge losses in recent years as sales of its iconic white tennis Read More →
Sientra’s CEO tells of startup’s struggle and success
In 2007, it seemed like an simple path to success: Sientra, a startup led by breast implant industry veterans, would acquire a portfolio of silicone implants, raise money and seek approval from the U.S. Food and Drug Administration to become the first new player in the industry in two decades. Between then and now, however, Read More →
Lynda.com raises $103M
In a move that could change online education, Carpinteria-based lynda.com has raised $103 milllion from a group of investors, marking the first time the company has taken outside funding in its 17-year history. Lynda.com, one of the fastest-growing firms in the Tri-Counties, employs about 400 people and generated $100 million in revenue in 2012. It Read More →
Limoneira predicts sales gains after profits dip
Santa Paula-based Limoneira Co. said fourth-quarter revenue jumped sharply but that it experienced a decline in profit because of expenses for Sheldon Ranch, a new 1,000-acre lemon and citrus leasehold that is expected to be profitable in 2013. The company said it expects strong results from those lemon and citrus in 2013, when it also Read More →
U.S Bank CEO speaks in Santa Barbara
Sometimes, uncertainty is a good thing. That was one view from Richard K. Davis, the head of U.S. Bank, as he spoke in Montecito on Jan. 11 Davis is the president of the Federal Advisory Council of bankers that consults with the board of governors of the Federal Reserve System. He said he has often Read More →
Amgen inks $180M nanomedicine deal
Thousand Oaks-based Amgen has entered a deal to pay up to $180.5 million for nanomedicine tumor treatments being developed by a Massachusetts company. Cambridge-based Bind Biosciences said it has entered a development agreement with Amgen for its kinase inhibitor nanomedicines for treating a range of solid tumors. The medicines are highly targeted and can be Read More →
